Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Monteleone

Showing results (61-70 of 384) with videos related to

Pageof 39
Sort By:
Trends in Immunology|April 29, 2008
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responsesGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Current Opinion in Pharmacology|October 18, 2011
Emerging immunological targets in inflammatory bowel diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Cytokine & Growth Factor Reviews|March 6, 2009
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
Journal of Clinical Medicine|December 10, 2021
Long COVID in Inflammatory Bowel DiseasesSilvia Salvatori, Francesco Baldassarre, Michelangela Mossa, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2018
Oligonucleotide-Based Therapies for Inflammatory Bowel DiseaseGerolamo Bevivino, Silvia Sedda, Irene Marafini, et al.
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Interleukin-21 (IL-21) controls inflammatory pathways in the gutDaniele Fina, Roberta Caruso, Francesco Pallone, et al.
World Journal of Gastroenterology|September 25, 2012
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?Stella Tammaro, Roberta Caruso, Francesco Pallone, et al.
Pageof 39

Showing results (61-70 of 384) with videos related to

Sort By:
Pageof 39
Trends in Immunology|April 29, 2008
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responsesGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Current Opinion in Pharmacology|October 18, 2011
Emerging immunological targets in inflammatory bowel diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Cytokine & Growth Factor Reviews|March 6, 2009
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
Journal of Clinical Medicine|December 10, 2021
Long COVID in Inflammatory Bowel DiseasesSilvia Salvatori, Francesco Baldassarre, Michelangela Mossa, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2018
Oligonucleotide-Based Therapies for Inflammatory Bowel DiseaseGerolamo Bevivino, Silvia Sedda, Irene Marafini, et al.
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Interleukin-21 (IL-21) controls inflammatory pathways in the gutDaniele Fina, Roberta Caruso, Francesco Pallone, et al.
World Journal of Gastroenterology|September 25, 2012
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?Stella Tammaro, Roberta Caruso, Francesco Pallone, et al.
Pageof 39